• 1. Alumina coating on 5 V lithium cobalt fluorophosphate cathode material for lithium secondary batteries – synthesis and electrochemical properties?
  S. Amaresh,K. Karthikeyan,K. J. Kim,Y. S. Lee RSC Adv., 2014,4, 23107-23115
• 2. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 3. Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations?
  Somenath Panda,Kaushik Kundu,Anusha Basaiahgari,Sanjib Senapati,Ramesh L. Gardas New J. Chem., 2018,42, 7105-7118
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227

Introduction to 2-Chloro-3-propoxyphenylboronic acid (CAS No: 1256345-51-3)

2-Chloro-3-propoxyphenylboronic acid, identified by its Chemical Abstracts Service (CAS) number 1256345-51-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This boronic acid derivative is characterized by its unique structural properties, which make it a valuable intermediate in the synthesis of various high-value compounds. The presence of both a chloro and a propoxy substituent on the phenyl ring imparts distinct reactivity and functionalization possibilities, making it a versatile building block for drug development and advanced material applications.

The compound's structure, featuring a boronic acid functional group, positions it as a key intermediate in Suzuki-Miyaura cross-coupling reactions. These reactions are pivotal in modern synthetic organic chemistry, enabling the formation of carbon-carbon bonds under mild conditions. The boronic acid moiety's ability to participate in such transformations has made 2-Chloro-3-propoxyphenylboronic acid indispensable in the preparation of biaryl compounds, which are prevalent in many pharmacologically active molecules. Recent advancements in medicinal chemistry have highlighted its role in developing novel therapeutic agents, particularly those targeting complex biological pathways.

In the realm of drug discovery, 2-Chloro-3-propoxyphenylboronic acid has been employed in the synthesis of small-molecule inhibitors. For instance, studies have demonstrated its utility in generating proprietary scaffolds for kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The chloro and propoxy groups provide handles for further chemical modifications, allowing researchers to fine-tune physicochemical properties such as solubility, bioavailability, and metabolic stability. This flexibility is particularly valuable when designing molecules that must navigate biological membranes or evade enzymatic degradation.

The propoxy substituent on the phenyl ring also contributes to the compound's overall functionality. Propoxy groups are known to enhance lipophilicity while maintaining good water solubility, making them ideal for designing prodrugs or improving oral bioavailability. In recent years, there has been growing interest in leveraging boronic acids for targeted drug delivery systems. For example, 2-Chloro-3-propoxyphenylboronic acid has been explored as a component in ligand-conjugated nanoparticles designed for tumor-specific delivery. The boronic acid group can selectively bind to overexpressed receptors on cancer cells, facilitating localized drug release and minimizing systemic side effects.

Beyond pharmaceutical applications, 2-Chloro-3-propoxyphenylboronic acid finds utility in materials science. Its reactivity with metal catalysts allows for the synthesis of conjugated polymers and organic electronic materials. These materials are essential for developing next-generation technologies such as organic light-emitting diodes (OLEDs), photovoltaic cells, and flexible electronics. The compound's ability to form stable organoboron derivatives underpins its role in creating high-performance polymers with tailored electronic properties. Researchers have reported its incorporation into π-conjugated systems, which exhibit enhanced charge transport capabilities—a critical factor for efficient optoelectronic devices.

The synthesis of 2-Chloro-3-propoxyphenylboronic acid itself is an area of active research. Recent methodologies have focused on optimizing yields and minimizing byproducts through catalytic processes or green chemistry principles. For instance, microwave-assisted synthesis has been explored to accelerate reaction times while maintaining high selectivity. Additionally, biocatalytic approaches have been investigated as sustainable alternatives to traditional chemical transformations. These efforts align with global trends toward more environmentally responsible manufacturing practices.

In clinical trials and preclinical studies, derivatives of 2-Chloro-3-propoxyphenylboronic acid have shown promise as lead compounds for treating neurological disorders. The phenyl ring's aromaticity and the electron-withdrawing nature of the chloro group contribute to favorable interactions with biological targets such as G-protein coupled receptors (GPCRs) and ion channels. Furthermore, computational modeling studies have predicted that modifications at the propoxy position could enhance binding affinity without compromising safety profiles—a crucial consideration for drug candidates entering human trials.

The compound's stability under various storage conditions is another factor that underscores its practicality in industrial applications. Boronic acids are generally sensitive to moisture and air exposure; however, advancements in purification techniques and packaging materials have mitigated these challenges significantly. This stability ensures consistent quality throughout the supply chain, from research laboratories to large-scale manufacturing facilities.

Economic considerations also play a role in the adoption of 2-Chloro-3-propoxyphenylboronic acid. As demand for specialized intermediates grows, producers have invested in cost-effective synthetic routes that reduce reliance on expensive starting materials or rare catalysts. Such innovations make high-value compounds more accessible to academic institutions and smaller biotech firms alike—fostering broader participation in drug discovery initiatives.

The future outlook for 2-Chloro-3-propoxyphenylboronic acid remains bright as new applications continue to emerge across multiple disciplines. Ongoing research into its potential as an agrochemical intermediate or specialty chemical precursor further expands its utility beyond traditional pharmaceutical contexts. Collaborative efforts between chemists specializing in synthetic organic chemistry and experts in computational biology promise to unlock even more innovative uses for this versatile compound.

• 480438-57-1((3-Chloro-4-propoxyphenyl)boronic acid)
• 913835-30-0(2-Chloro-5-ethoxyphenylboronic acid)
• 1256355-00-6((4-Chloro-3-(2-methoxyethoxy)phenyl)boronic acid)
• 854778-30-6((2-Chloro-3-methoxyphenyl)boronic acid)
• 1256354-91-2(2,4-Dichloro-5-(cyclopropylmethoxy)phenylboronic acid)
• 1256346-45-8(2,4-Dichloro-5-propoxyphenylboronic acid)
• 900174-62-1((4-Chloro-3-ethoxyphenyl)boronic acid)
• 1256354-88-7(5-Butoxy-2,4-dichlorophenylboronic acid)
• 1256346-46-9((2,4-Dichloro-5-isobutoxyphenyl)boronic acid)
• 1256354-89-8(2,4-Dichloro-5-(2-methoxyethoxy)phenylboronic acid)